1/48
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
heterogeneous metabolic disorder characterized by hyperglycemia
define diacetates mellitus
macrovascular and microvascular
chronic hyperglycemia is associated with ____ and ___ complications
thirst, frequent urination, weight change, blurred vision, infections, slow healing, numbness, erectile disfunction
what are the symptoms of diabetes
heart and brain disease, kidney disease, eye disease, nerve damage
what are the consequences of diabetes
6 yrs
how much lower is life expectancy of those with diabetes
1 in 9 adults
how many adults have diabetes (ratio)
the ability to use and produce insulin decreases over time
why does the risk of diabetes increase with age
type 1
pancreatic beta cell destruction, usually leading to absolute insulin deficiency
immune mediated
in type 1 diabetes: the destruction of pancreatic beta cells is driven by an autoimmune process mediated by macrophages and T lymphocytes with circulating autoantibodies targeting B cell antigens
type 2 diabetes
may range from predominantly insulin resistance insulin deficiency to a predominantly secretory defect with insulin resistance
gestational
glucose intolerance with onset or first recognition in pregnancy
Glycated hemoglobin
this test measures the level of stickiness where glucose attaches to hemoglobin molecules in the blood
plasma glucose criteria
diagnosis of diabetes is confirmed if: fasting plasma glucose > 1.7 mmol/L, Oral glucose tolerance test >11.1 mmol/L, random plasma glucose > 11.1
beta cells release insulin into the blood
when blood glucose levels rise, what happens in the pancreas
stores glucose as glycogen
when blood glucose levels rise, what happens in the liver
alpha cells release glucagon
when blood glucose levels fall, what happens in the pancreas
breakdown glycogen to release glucose
when blood glucose levels fall what happens in the liver
insulin and glucagon
what are the two main hormones that regulate glucose in the body?
glycogenolysis, gluconeogenesis
what processes does the liver use to produce glucose
gluconeogenesis
what process does the kidney use to produce glucose
fed state
fed or fasted state: high insulin low glucagon
fed or fasted state: low insulin, high glucagon
plasma
where does the brain get its glucose
ketone bodies
after prolonged fasting, ___ ___ are produced and available to the brain for energy
liver, kidney
in fed state, glucose release by ___ is suppressed, glucose released by __ isnt suppressed
glycogenolysis
in the fasted state, the release of glucagon stimulates ___
gluconeogenesis
in fasted state when glycogen stores are depleted, the body relies more on ___
fats and protein
in the starvation state, the body starts to rely on ___ and ____ for energy
ketones
biproduct of breaking down FFA for energy
pancreas
which organ: produces and secretes digestive enzymes and hormones for glucose regulation
glucagon
major counterpart to insulin, increases plasma glucose via stimulation of hepatic glycogenolysis, secretion stimulated by hypoglycemia and inhibited by hyperglycemia
insulin
regulates glucose via direct and indirect mechanisms, secretion regulated by plasma glucose concentration
epinephrine and norepinephrine
catecholamines - increase glucose via glycogenolysis, gluconeogenesis, lipolysis, and are fast acting
growth hormone and cortisol
slow acting, increase glucose via stimulation of gluconeogenic enzymes and reduction of glucose transport, impairs insulin secretion
Free Fatty acids
predominant fuel used by most organs, stimulate glucose production in liver and kidney via gluconeogenesis, impair glucose transport into muscle tissue, regulators are sympathetic nervous system, growth hormone, insulin, hyperglycemia
incretins
hormones secreted by the gut that stimulate insulin release from pancreas
GLP1
which incretin is deficient in type 2 diabetes
GLP1
____ inhibits glucagon secretion, delays gastric emptying, promotes satiety
type 1
pathogenesis of what type: pre-clinical period of autoimmune destruction of beta cells in pancreas, genetic predisposition and immune trigger
type 1
what type: destruction of pancreatic beta-cells, onset is typically rapid, absolute insulin deficiency, exogenous insulin required for survival, accounts for 5-10% of diabetes cases, autoimmune markers often present
islet autoantibody testing
used to distinguish between type 1 diabetes and type 2 diabetes or monogenic diabetes
C-peptide
measure of endogenous insulin secretion, most helpful 3-5 years after diagnosis, high = type 2
Latent autoimmune diabetes in adults
type 1.5, misdiagnosed as type 2, often > 30 years old, slower progression of autoimmune beta cell failure, islet antibodies present at diagnosis
genetics, environment
risk factors of type 1 diabetes
type 2
pathogenesis of what type: predominant relative insulin deficiency or predominant insulin resistance or both
type 2
what type: gradual onset, obese/sedentary lifestyle, older, positive family history, symptoms - may have none
hyperglycemia, acute, chronic
primary goals of therapy:
avoid symptoms of ____
avoid risk of ___ complications
reduce risk of ___ complications
acute complications
hypoglycemia and hyperglycemic emergencies such as diabetic ketoacidosis and hyperosmolar hyperglycemic states are examples of what
chronic complications
microvascular - cerebrovascular disease, coronary heart disease, peripheral vascular disease are examples of what